Expression  ||| S:0 E:11 ||| NN
profiles  ||| S:11 E:20 ||| NNS
of  ||| S:20 E:23 ||| IN
inhibitor  ||| S:23 E:33 ||| NN
of  ||| S:33 E:36 ||| IN
growth  ||| S:36 E:43 ||| NN
protein 2  ||| S:43 E:53 ||| NN
in  ||| S:53 E:56 ||| IN
normal  ||| S:56 E:63 ||| JJ
and  ||| S:63 E:67 ||| CC
cancer  ||| S:67 E:74 ||| NN
tissues ||| S:74 E:81 ||| NNS
:  ||| S:81 E:83 ||| :
An  ||| S:83 E:86 ||| DT
immunohistochemical  ||| S:86 E:106 ||| JJ
screening  ||| S:106 E:116 ||| NN
analysis  ||| S:116 E:125 ||| NN
Inhibitor  ||| S:125 E:135 ||| NNS
of  ||| S:135 E:138 ||| IN
growth  ||| S:138 E:145 ||| NN
protein 2  ||| S:145 E:155 ||| NNP
( ||| S:155 E:156 ||| -LRB-
ING2 ||| S:156 E:160 ||| NNP
)  ||| S:160 E:162 ||| -RRB-
has  ||| S:162 E:166 ||| VBZ
an  ||| S:166 E:169 ||| DT
important  ||| S:169 E:179 ||| JJ
role  ||| S:179 E:184 ||| NN
in  ||| S:184 E:187 ||| IN
the  ||| S:187 E:191 ||| DT
regulation  ||| S:191 E:202 ||| NN
of  ||| S:202 E:205 ||| IN
chromatin  ||| S:205 E:215 ||| JJ
remodeling ||| S:215 E:225 ||| NN
,  ||| S:225 E:227 ||| ,
cell  ||| S:227 E:232 ||| NN
proliferation ||| S:232 E:245 ||| NN
,  ||| S:245 E:247 ||| ,
cell‑cycle  ||| S:247 E:258 ||| CD
arrest ||| S:258 E:264 ||| NN
,  ||| S:264 E:266 ||| ,
senescence  ||| S:266 E:277 ||| NN
and  ||| S:277 E:281 ||| CC
apoptosis ||| S:281 E:290 ||| NN
.  ||| S:290 E:292 ||| .
The  ||| S:292 E:296 ||| DT
present  ||| S:296 E:304 ||| JJ
study  ||| S:304 E:310 ||| NN
performed  ||| S:310 E:320 ||| VBD
an  ||| S:320 E:323 ||| DT
immunohistochemical  ||| S:323 E:343 ||| JJ
analysis  ||| S:343 E:352 ||| NN
for  ||| S:352 E:356 ||| IN
expression  ||| S:356 E:367 ||| NN
profiling  ||| S:367 E:377 ||| NN
of  ||| S:377 E:380 ||| IN
ING2  ||| S:380 E:385 ||| CD
protein  ||| S:385 E:393 ||| NN
in  ||| S:393 E:396 ||| IN
an  ||| S:396 E:399 ||| DT
array  ||| S:399 E:405 ||| NN
of  ||| S:405 E:408 ||| IN
tissues  ||| S:408 E:416 ||| NNS
comprising  ||| S:416 E:427 ||| VBG
normal  ||| S:427 E:434 ||| JJ
mouse  ||| S:434 E:440 ||| NN
and  ||| S:440 E:444 ||| CC
human  ||| S:444 E:450 ||| JJ
tissues ||| S:450 E:457 ||| NNS
,  ||| S:457 E:459 ||| ,
as  ||| S:459 E:462 ||| RB
well  ||| S:462 E:467 ||| RB
as  ||| S:467 E:470 ||| IN
human  ||| S:470 E:476 ||| JJ
hepatocellular  ||| S:476 E:491 ||| NNS
( ||| S:491 E:492 ||| -LRB-
n=62 ||| S:492 E:496 ||| NNP
) ||| S:496 E:497 ||| -RRB-
,  ||| S:497 E:499 ||| ,
renal  ||| S:499 E:505 ||| JJ
clear  ||| S:505 E:511 ||| JJ
cell  ||| S:511 E:516 ||| NN
( ||| S:516 E:517 ||| -LRB-
n=62 ||| S:517 E:521 ||| NNP
) ||| S:521 E:522 ||| -RRB-
,  ||| S:522 E:524 ||| ,
pancreatic  ||| S:524 E:535 ||| NNS
( ||| S:535 E:536 ||| -LRB-
n=62 ||| S:536 E:540 ||| NNP
) ||| S:540 E:541 ||| -RRB-
,  ||| S:541 E:543 ||| ,
esophageal  ||| S:543 E:554 ||| JJ
squamous  ||| S:554 E:563 ||| JJ
cell  ||| S:563 E:568 ||| NN
( ||| S:568 E:569 ||| -LRB-
n=45 ||| S:569 E:573 ||| NNP
) ||| S:573 E:574 ||| -RRB-
,  ||| S:574 E:576 ||| ,
cervical  ||| S:576 E:585 ||| JJ
squamous  ||| S:585 E:594 ||| JJ
cell  ||| S:594 E:599 ||| NN
( ||| S:599 E:600 ||| -LRB-
n=31 ||| S:600 E:604 ||| NNP
) ||| S:604 E:605 ||| -RRB-
,  ||| S:605 E:607 ||| ,
breast  ||| S:607 E:614 ||| NN
( ||| S:614 E:615 ||| -LRB-
n=144 ||| S:615 E:620 ||| NNP
) ||| S:620 E:621 ||| -RRB-
,  ||| S:621 E:623 ||| ,
gastric  ||| S:623 E:631 ||| NNS
( ||| S:631 E:632 ||| -LRB-
n=196 ||| S:632 E:637 ||| NNP
) ||| S:637 E:638 ||| -RRB-
,  ||| S:638 E:640 ||| ,
colorectal  ||| S:640 E:651 ||| NNS
( ||| S:651 E:652 ||| -LRB-
n=96 ||| S:652 E:656 ||| NNP
) ||| S:656 E:657 ||| -RRB-
,  ||| S:657 E:659 ||| ,
ovarian  ||| S:659 E:667 ||| NNS
( ||| S:667 E:668 ||| -LRB-
n=208 ||| S:668 E:673 ||| NNP
) ||| S:673 E:674 ||| -RRB-
,  ||| S:674 E:676 ||| ,
endometrial  ||| S:676 E:688 ||| NNS
( ||| S:688 E:689 ||| -LRB-
n=96 ||| S:689 E:693 ||| NNP
)  ||| S:693 E:695 ||| -RRB-
and  ||| S:695 E:699 ||| CC
lung  ||| S:699 E:704 ||| NN
( ||| S:704 E:705 ||| -LRB-
n=192 ||| S:705 E:710 ||| NNP
)  ||| S:710 E:712 ||| -RRB-
carcinoma  ||| S:712 E:722 ||| JJ
tissues ||| S:722 E:729 ||| NNS
.  ||| S:729 E:731 ||| .
In  ||| S:731 E:734 ||| IN
mouse  ||| S:734 E:740 ||| NN
tissues ||| S:740 E:747 ||| NNS
,  ||| S:747 E:749 ||| ,
ING2  ||| S:749 E:754 ||| NNP
was  ||| S:754 E:758 ||| VBD
detected  ||| S:758 E:767 ||| VBN
in  ||| S:767 E:770 ||| IN
the  ||| S:770 E:774 ||| DT
nuclei  ||| S:774 E:781 ||| NN
and  ||| S:781 E:785 ||| CC
cytoplasm  ||| S:785 E:795 ||| NN
of  ||| S:795 E:798 ||| IN
the  ||| S:798 E:802 ||| DT
glandular  ||| S:802 E:812 ||| JJ
epithelium  ||| S:812 E:823 ||| NN
of  ||| S:823 E:826 ||| IN
breast ||| S:826 E:832 ||| NN
,  ||| S:832 E:834 ||| ,
hepatocytes ||| S:834 E:845 ||| NN
,  ||| S:845 E:847 ||| ,
intestine ||| S:847 E:856 ||| NN
,  ||| S:856 E:858 ||| ,
bronchium  ||| S:858 E:868 ||| NN
and  ||| S:868 E:872 ||| CC
alveoli ||| S:872 E:879 ||| NN
,  ||| S:879 E:881 ||| ,
as  ||| S:881 E:884 ||| RB
well  ||| S:884 E:889 ||| RB
as  ||| S:889 E:892 ||| IN
the  ||| S:892 E:896 ||| DT
squamous  ||| S:896 E:905 ||| JJ
epithelium  ||| S:905 E:916 ||| NN
of  ||| S:916 E:919 ||| IN
skin  ||| S:919 E:924 ||| NN
and  ||| S:924 E:928 ||| CC
glomeruli ||| S:928 E:937 ||| NN
,  ||| S:937 E:939 ||| ,
and  ||| S:939 E:943 ||| CC
in  ||| S:943 E:946 ||| IN
myocardial  ||| S:946 E:957 ||| JJ
cells ||| S:957 E:962 ||| NNS
,  ||| S:962 E:964 ||| ,
while  ||| S:964 E:970 ||| IN
it  ||| S:970 E:973 ||| PRP
was  ||| S:973 E:977 ||| VBD
located  ||| S:977 E:985 ||| VBN
in  ||| S:985 E:988 ||| IN
the  ||| S:988 E:992 ||| DT
cytoplasm  ||| S:992 E:1002 ||| NN
of  ||| S:1002 E:1005 ||| IN
renal  ||| S:1005 E:1011 ||| JJ
tubules  ||| S:1011 E:1019 ||| NN
and  ||| S:1019 E:1023 ||| CC
striated  ||| S:1023 E:1032 ||| JJ
muscle  ||| S:1032 E:1039 ||| NN
cells ||| S:1039 E:1044 ||| NNS
.  ||| S:1044 E:1046 ||| .
ING2  ||| S:1046 E:1051 ||| NNP
protein  ||| S:1051 E:1059 ||| NN
was  ||| S:1059 E:1063 ||| VBD
scattered  ||| S:1063 E:1073 ||| VBN
in  ||| S:1073 E:1076 ||| IN
the  ||| S:1076 E:1080 ||| DT
brain  ||| S:1080 E:1086 ||| NN
and  ||| S:1086 E:1090 ||| CC
spleen ||| S:1090 E:1096 ||| NN
.  ||| S:1096 E:1098 ||| .
In  ||| S:1098 E:1101 ||| IN
human  ||| S:1101 E:1107 ||| JJ
tissues ||| S:1107 E:1114 ||| NNS
,  ||| S:1114 E:1116 ||| ,
ING2  ||| S:1116 E:1121 ||| CD
protein  ||| S:1121 E:1129 ||| NN
was  ||| S:1129 E:1133 ||| VBD
principally  ||| S:1133 E:1145 ||| RB
distributed  ||| S:1145 E:1157 ||| VBN
in  ||| S:1157 E:1160 ||| IN
the  ||| S:1160 E:1164 ||| DT
cytoplasm ||| S:1164 E:1173 ||| NN
,  ||| S:1173 E:1175 ||| ,
while  ||| S:1175 E:1181 ||| IN
in  ||| S:1181 E:1184 ||| IN
it  ||| S:1184 E:1187 ||| PRP
was  ||| S:1187 E:1191 ||| VBD
present  ||| S:1191 E:1199 ||| JJ
in  ||| S:1199 E:1202 ||| IN
the  ||| S:1202 E:1206 ||| DT
cytoplasm  ||| S:1206 E:1216 ||| NN
and  ||| S:1216 E:1220 ||| CC
nuclei  ||| S:1220 E:1227 ||| NN
in  ||| S:1227 E:1230 ||| IN
the  ||| S:1230 E:1234 ||| DT
stomach ||| S:1234 E:1241 ||| NN
,  ||| S:1241 E:1243 ||| ,
intestine ||| S:1243 E:1252 ||| NN
,  ||| S:1252 E:1254 ||| ,
cervix ||| S:1254 E:1260 ||| NN
,  ||| S:1260 E:1262 ||| ,
endometrium  ||| S:1262 E:1274 ||| JJ
trachea ||| S:1274 E:1281 ||| NN
,  ||| S:1281 E:1283 ||| ,
breast  ||| S:1283 E:1290 ||| NN
and  ||| S:1290 E:1294 ||| CC
pancreas ||| S:1294 E:1302 ||| NN
.  ||| S:1302 E:1304 ||| .
The  ||| S:1304 E:1308 ||| DT
nuclear  ||| S:1308 E:1316 ||| JJ
location  ||| S:1316 E:1325 ||| NN
of  ||| S:1325 E:1328 ||| IN
ING2  ||| S:1328 E:1333 ||| CD
in  ||| S:1333 E:1336 ||| IN
the  ||| S:1336 E:1340 ||| DT
stomach  ||| S:1340 E:1348 ||| NN
was  ||| S:1348 E:1352 ||| VBD
more  ||| S:1352 E:1357 ||| RBR
prominent  ||| S:1357 E:1367 ||| JJ
than  ||| S:1367 E:1372 ||| IN
that  ||| S:1372 E:1377 ||| DT
in  ||| S:1377 E:1380 ||| IN
the  ||| S:1380 E:1384 ||| DT
cytoplasm ||| S:1384 E:1393 ||| NN
.  ||| S:1393 E:1395 ||| .
High  ||| S:1395 E:1400 ||| JJ
ING2  ||| S:1400 E:1405 ||| CD
immunoreactivity  ||| S:1405 E:1422 ||| NNS
was  ||| S:1422 E:1426 ||| VBD
detected  ||| S:1426 E:1435 ||| VBN
in  ||| S:1435 E:1438 ||| IN
the  ||| S:1438 E:1442 ||| DT
tongue ||| S:1442 E:1448 ||| NN
,  ||| S:1448 E:1450 ||| ,
stomach ||| S:1450 E:1457 ||| NN
,  ||| S:1457 E:1459 ||| ,
skin ||| S:1459 E:1463 ||| NN
,  ||| S:1463 E:1465 ||| ,
pancreas ||| S:1465 E:1473 ||| NN
,  ||| S:1473 E:1475 ||| ,
cervix  ||| S:1475 E:1482 ||| NN
and  ||| S:1482 E:1486 ||| CC
breast ||| S:1486 E:1492 ||| NN
,  ||| S:1492 E:1494 ||| ,
whereas  ||| S:1494 E:1502 ||| IN
weakly  ||| S:1502 E:1509 ||| NN
in  ||| S:1509 E:1512 ||| IN
the  ||| S:1512 E:1516 ||| DT
brain  ||| S:1516 E:1522 ||| NN
stem ||| S:1522 E:1526 ||| NN
,  ||| S:1526 E:1528 ||| ,
thymus ||| S:1528 E:1534 ||| NN
,  ||| S:1534 E:1536 ||| ,
thyroid ||| S:1536 E:1543 ||| NN
,  ||| S:1543 E:1545 ||| ,
lung ||| S:1545 E:1549 ||| NN
,  ||| S:1549 E:1551 ||| ,
striated  ||| S:1551 E:1560 ||| JJ
muscle ||| S:1560 E:1566 ||| NN
,  ||| S:1566 E:1568 ||| ,
testis ||| S:1568 E:1574 ||| NN
,  ||| S:1574 E:1576 ||| ,
bladder  ||| S:1576 E:1584 ||| NN
and  ||| S:1584 E:1588 ||| CC
ovary ||| S:1588 E:1593 ||| NN
.  ||| S:1593 E:1595 ||| .
In  ||| S:1595 E:1598 ||| IN
total ||| S:1598 E:1603 ||| NN
,  ||| S:1603 E:1605 ||| ,
617  ||| S:1605 E:1609 ||| CD
out  ||| S:1609 E:1613 ||| IN
of  ||| S:1613 E:1616 ||| IN
1,194  ||| S:1616 E:1622 ||| CD
of  ||| S:1622 E:1625 ||| IN
the  ||| S:1625 E:1629 ||| DT
tested  ||| S:1629 E:1636 ||| JJ
cancer  ||| S:1636 E:1643 ||| NN
tissues  ||| S:1643 E:1651 ||| NNS
( ||| S:1651 E:1652 ||| -LRB-
51.7 ||| S:1652 E:1656 ||| NNP
% ||| S:1656 E:1657 ||| NN
)  ||| S:1657 E:1659 ||| -RRB-
were  ||| S:1659 E:1664 ||| VBD
ING2-positive ||| S:1664 E:1677 ||| CD
.  ||| S:1677 E:1679 ||| .
In  ||| S:1679 E:1682 ||| IN
most  ||| S:1682 E:1687 ||| JJS
cases ||| S:1687 E:1692 ||| NNS
,  ||| S:1692 E:1694 ||| ,
ING2  ||| S:1694 E:1699 ||| CD
expression  ||| S:1699 E:1710 ||| NN
was  ||| S:1710 E:1714 ||| VBD
found  ||| S:1714 E:1720 ||| VBN
to  ||| S:1720 E:1723 ||| TO
be  ||| S:1723 E:1726 ||| VB
restricted  ||| S:1726 E:1737 ||| VBN
to  ||| S:1737 E:1740 ||| TO
the  ||| S:1740 E:1744 ||| DT
cytoplasm  ||| S:1744 E:1754 ||| NN
of  ||| S:1754 E:1757 ||| IN
all  ||| S:1757 E:1761 ||| DT
cancer  ||| S:1761 E:1768 ||| NN
tissues ||| S:1768 E:1775 ||| NNS
,  ||| S:1775 E:1777 ||| ,
while  ||| S:1777 E:1783 ||| IN
in  ||| S:1783 E:1786 ||| IN
certain  ||| S:1786 E:1794 ||| JJ
cancer  ||| S:1794 E:1801 ||| NN
types ||| S:1801 E:1806 ||| NNS
,  ||| S:1806 E:1808 ||| ,
including  ||| S:1808 E:1818 ||| VBG
renal  ||| S:1818 E:1824 ||| JJ
clear  ||| S:1824 E:1830 ||| JJ
cell ||| S:1830 E:1834 ||| NN
,  ||| S:1834 E:1836 ||| ,
ovarian  ||| S:1836 E:1844 ||| NN
and  ||| S:1844 E:1848 ||| CC
colorectal  ||| S:1848 E:1859 ||| JJ
carcinoma ||| S:1859 E:1868 ||| NN
,  ||| S:1868 E:1870 ||| ,
it  ||| S:1870 E:1873 ||| PRP
was  ||| S:1873 E:1877 ||| VBD
occasionally  ||| S:1877 E:1890 ||| RB
present  ||| S:1890 E:1898 ||| VB
in  ||| S:1898 E:1901 ||| IN
the  ||| S:1901 E:1905 ||| DT
nuclei ||| S:1905 E:1911 ||| NN
.  ||| S:1911 E:1913 ||| .
Among  ||| S:1913 E:1919 ||| IN
the  ||| S:1919 E:1923 ||| DT
cancer  ||| S:1923 E:1930 ||| NN
tissues  ||| S:1930 E:1938 ||| NNS
examined ||| S:1938 E:1946 ||| VBD
,  ||| S:1946 E:1948 ||| ,
ING2  ||| S:1948 E:1953 ||| NNP
was  ||| S:1953 E:1957 ||| VBD
most  ||| S:1957 E:1962 ||| RBS
frequently  ||| S:1962 E:1973 ||| RB
expressed  ||| S:1973 E:1983 ||| VBN
in  ||| S:1983 E:1986 ||| IN
breast  ||| S:1986 E:1993 ||| JJ
cancer  ||| S:1993 E:2000 ||| NN
( ||| S:2000 E:2001 ||| -LRB-
67.4 ||| S:2001 E:2005 ||| NNP
% ||| S:2005 E:2006 ||| NN
)  ||| S:2006 E:2008 ||| -RRB-
and  ||| S:2008 E:2012 ||| CC
gynecological  ||| S:2012 E:2026 ||| JJ
cancer  ||| S:2026 E:2033 ||| NN
types ||| S:2033 E:2038 ||| NNS
,  ||| S:2038 E:2040 ||| ,
including  ||| S:2040 E:2050 ||| VBG
ovarian  ||| S:2050 E:2058 ||| JJ
cancer  ||| S:2058 E:2065 ||| NN
( ||| S:2065 E:2066 ||| -LRB-
61.5 ||| S:2066 E:2070 ||| NNP
% ||| S:2070 E:2071 ||| NN
)  ||| S:2071 E:2073 ||| -RRB-
and  ||| S:2073 E:2077 ||| CC
endometrial  ||| S:2077 E:2089 ||| JJ
cancer  ||| S:2089 E:2096 ||| NN
( ||| S:2096 E:2097 ||| -LRB-
57.3 ||| S:2097 E:2101 ||| NNP
% ||| S:2101 E:2102 ||| NN
) ||| S:2102 E:2103 ||| -RRB-
.  ||| S:2103 E:2105 ||| .
Compared  ||| S:2105 E:2114 ||| VBN
with  ||| S:2114 E:2119 ||| IN
that  ||| S:2119 E:2124 ||| DT
in  ||| S:2124 E:2127 ||| IN
the  ||| S:2127 E:2131 ||| DT
respective  ||| S:2131 E:2142 ||| JJ
normal  ||| S:2142 E:2149 ||| JJ
tissues ||| S:2149 E:2156 ||| NNS
,  ||| S:2156 E:2158 ||| ,
ING2  ||| S:2158 E:2163 ||| CD
expression  ||| S:2163 E:2174 ||| NN
in  ||| S:2174 E:2177 ||| IN
breast  ||| S:2177 E:2184 ||| JJ
cancer  ||| S:2184 E:2191 ||| NN
tissues  ||| S:2191 E:2199 ||| NNS
was  ||| S:2199 E:2203 ||| VBD
decreased ||| S:2203 E:2212 ||| VBN
,  ||| S:2212 E:2214 ||| ,
while  ||| S:2214 E:2220 ||| IN
that  ||| S:2220 E:2225 ||| DT
in  ||| S:2225 E:2228 ||| IN
cervical  ||| S:2228 E:2237 ||| JJ
cancer  ||| S:2237 E:2244 ||| NN
was  ||| S:2244 E:2248 ||| VBD
upregulated  ||| S:2248 E:2260 ||| VBN
in  ||| S:2260 E:2263 ||| IN
the  ||| S:2263 E:2267 ||| DT
nuclei  ||| S:2267 E:2274 ||| NN
as  ||| S:2274 E:2277 ||| IN
well  ||| S:2277 E:2282 ||| RB
as  ||| S:2282 E:2285 ||| IN
the  ||| S:2285 E:2289 ||| DT
cytoplasm ||| S:2289 E:2298 ||| NN
.  ||| S:2298 E:2300 ||| .
In  ||| S:2300 E:2303 ||| IN
endometrial  ||| S:2303 E:2315 ||| JJ
cancer ||| S:2315 E:2321 ||| NN
,  ||| S:2321 E:2323 ||| ,
expression  ||| S:2323 E:2334 ||| NN
of  ||| S:2334 E:2337 ||| IN
ING2  ||| S:2337 E:2342 ||| NNP
was  ||| S:2342 E:2346 ||| VBD
increased  ||| S:2346 E:2356 ||| VBN
in  ||| S:2356 E:2359 ||| IN
the  ||| S:2359 E:2363 ||| DT
nuclei  ||| S:2363 E:2370 ||| NN
and  ||| S:2370 E:2374 ||| CC
declined  ||| S:2374 E:2383 ||| VBD
in  ||| S:2383 E:2386 ||| IN
the  ||| S:2386 E:2390 ||| DT
cytoplasm  ||| S:2390 E:2400 ||| NN
compared  ||| S:2400 E:2409 ||| VBN
with  ||| S:2409 E:2414 ||| IN
that  ||| S:2414 E:2419 ||| DT
in  ||| S:2419 E:2422 ||| IN
the  ||| S:2422 E:2426 ||| DT
normal  ||| S:2426 E:2433 ||| JJ
endometrium ||| S:2433 E:2444 ||| NN
.  ||| S:2444 E:2446 ||| .
ING2‑positive  ||| S:2446 E:2460 ||| NNP
cases  ||| S:2460 E:2466 ||| NNS
were  ||| S:2466 E:2471 ||| VBD
less  ||| S:2471 E:2476 ||| RBR
frequent  ||| S:2476 E:2485 ||| JJ
for  ||| S:2485 E:2489 ||| IN
renal  ||| S:2489 E:2495 ||| JJ
clear  ||| S:2495 E:2501 ||| JJ
cell  ||| S:2501 E:2506 ||| NN
carcinoma  ||| S:2506 E:2516 ||| NNS
( ||| S:2516 E:2517 ||| -LRB-
17.7 ||| S:2517 E:2521 ||| CD
% ||| S:2521 E:2522 ||| NN
) ||| S:2522 E:2523 ||| -RRB-
.  ||| S:2523 E:2525 ||| .
The  ||| S:2525 E:2529 ||| DT
results  ||| S:2529 E:2537 ||| NNS
of  ||| S:2537 E:2540 ||| IN
the  ||| S:2540 E:2544 ||| DT
present  ||| S:2544 E:2552 ||| JJ
study  ||| S:2552 E:2558 ||| NN
suggested  ||| S:2558 E:2568 ||| VBD
that  ||| S:2568 E:2573 ||| IN
ING2  ||| S:2573 E:2578 ||| NNP
may  ||| S:2578 E:2582 ||| MD
be  ||| S:2582 E:2585 ||| VB
involved  ||| S:2585 E:2594 ||| VBN
in  ||| S:2594 E:2597 ||| IN
the  ||| S:2597 E:2601 ||| DT
repair  ||| S:2601 E:2608 ||| NN
and  ||| S:2608 E:2612 ||| CC
regeneration  ||| S:2612 E:2625 ||| NN
of  ||| S:2625 E:2628 ||| IN
organs  ||| S:2628 E:2635 ||| NNS
or  ||| S:2635 E:2638 ||| CC
tissues  ||| S:2638 E:2646 ||| NNS
and  ||| S:2646 E:2650 ||| CC
is  ||| S:2650 E:2653 ||| VBZ
associated  ||| S:2653 E:2664 ||| VBN
with  ||| S:2664 E:2669 ||| IN
breast  ||| S:2669 E:2676 ||| NN
and  ||| S:2676 E:2680 ||| CC
gynecological  ||| S:2680 E:2694 ||| JJ
carcinogenesis ||| S:2694 E:2708 ||| NN
.  ||| S:2708 E:2710 ||| .
